Welcome to our dedicated page for Healthlynked news (Ticker: HLYK), a resource for investors and traders seeking the latest updates and insights on Healthlynked stock.
HealthLynked Corp. (HLYK) is a healthcare technology company whose news flow centers on AI-enabled care coordination, patient engagement, payer partnerships, and digital health innovation. The HLYK news page on Stock Titan aggregates press releases and market updates so readers can follow how the company advances its platform connecting patients, providers, payers, and researchers.
Recent announcements highlight HealthLynked’s focus on AI-driven healthcare tools, including its ARI AI healthcare guide and multilingual health assistant, as well as new patent filings in AI care management, universal patient identifiers, and secure medical record access. News items also cover initiatives to expand interoperability, telemedicine, and cloud-based medical record sharing that underpin the company’s patient-centric network.
Investors and healthcare professionals can track strategic partnerships and corporate developments, such as engagements with advisory firms to support capital markets strategy and potential uplisting, collaborations with payer-focused organizations to accelerate value-based care, and the addition of experienced insurance and benefits executives to the board and management team. These updates provide insight into HealthLynked’s efforts to deepen relationships with insurers, employer groups, ACOs, and enterprise partners.
Operational news includes the launch of an upgraded MedOfficeDirect e-commerce platform for medical and dental supplies, enhancements to the enterprise solutions website, and improvements to the national provider directory. Together, these stories illustrate how HealthLynked is evolving its technology, expanding its ecosystem, and pursuing research partnerships that leverage its patient network and AI capabilities. Bookmark this page to follow earnings-related disclosures, platform launches, strategic agreements, and regulatory filings that shape the ongoing narrative around HLYK.
HealthLynked (OTCQB: HLYK), a connected healthcare technology company, has appointed Andrew Mavliev as its new Chief Technology and Product Officer. Mavliev brings over 15 years of experience in technology strategy, product development, and operational leadership to the company.
Mavliev previously served as founding Chief Technology Officer at Aram Meem LLC (ToYou superapp), where he led the development of a super app platform serving millions of users. He holds a degree in Applied Mathematics and an MBA from the University of Chicago Booth School of Business.
The appointment aligns with HealthLynked's focus on developing its integrated digital ecosystem, which includes the ARi virtual assistant, a telehealth platform, and unified medical record management. The company aims to revolutionize healthcare delivery through AI-powered experiences and enhanced patient-provider connectivity.
HealthLynked (OTCQB: HLYK) has announced a strategic partnership with healthcare data integration firm Endlink to enhance connectivity between hospital systems and electronic medical records (EMRs). The collaboration brings together Endlink's CTO Rubén Viera, who has over 25 years of healthcare technology experience, with HealthLynked's patient engagement platform.
Endlink's platform currently serves over 300,000 members in Puerto Rico and has improved specialist consultation response times by up to 66% across two major hospital systems. The partnership aims to integrate HealthLynked's suite of tools into Endlink's existing hospital and payer client base, potentially creating new revenue streams through enhanced data integration and workflow automation capabilities.
HealthLynked (OTCQB: HLYK) has announced significant enhancements to its healthcare platform, introducing new appointment booking features and a provider review system. The platform now offers four key booking options: date and time-specific booking with in-network providers for all users, concierge appointment requests for out-of-network providers (Concierge Members only), specialty-based appointment requests without selecting specific providers (Concierge Members only), and updated appointment reasons by medical specialty for all users.
The company has also launched an enhanced provider review system allowing users to submit star ratings and narrative reviews, helping patients make more informed healthcare decisions. These improvements aim to streamline healthcare access and improve patient experiences across HealthLynked's growing provider network.
HealthLynked Corp. (OTCQB: HLYK) has appointed Anthony 'Tony' Scuilla as a strategic sales consultant to focus on securing partnerships with large insurance providers. Scuilla brings over 35 years of executive experience in healthcare information technology sales, having held key positions at AGS Healthcare Group, Alteer Corp., Eclipsys Corp., and Shared Medical Systems.
Throughout his career, Scuilla has launched products generating over $100 million in sales and successfully raised more than $20 million in venture capital. He has extensive experience in building national sales teams and advising healthcare companies on scaling strategies. Currently, he volunteers as a Patient Advocate at Gulf Coast Medical Center and mentors students at Florida Gulf Coast University Entrepreneurship Program.
HealthLynked (OTCQB: HLYK) has announced significant upgrades to its in-office appointment booking platform and ARi voice assistant. The enhanced booking system now offers patients more flexibility with features including next available time slot selection, specific day requests, and morning/afternoon preferences. Patients can also submit provider reviews without logging in, though these will appear as 'unverified'.
The ARi (Artificial Intelligence for Real-Time Interaction) voice assistant improvements focus on reduced background noise interference and prevention of unwanted interruptions through advanced noise-cancellation and detection algorithms. These updates aim to streamline doctor-patient communication and improve the overall healthcare experience for both patients and providers.
HealthLynked Corp. (OTCQB: HLYK) has released its Annual Shareholder Letter detailing key achievements in 2024 and strategic priorities for the future. The company launched several significant initiatives including: ARI, an AI-powered healthcare guidance system for personalized medical recommendations; nationwide expansion of 24/7 telemedicine services beyond Florida; introduction of a premium concierge service with monthly subscription; and implementation of a discount prescription drug program.
The company's growth strategy focuses on scaling its platform through innovative marketing campaigns and strategic partnerships. HealthLynked plans to enhance affinity marketing by collaborating with insurance providers, major employers, and professional employer organizations (PEOs) to expand its membership base. The company's vision centers on transforming healthcare through improved care management, increased healthcare access, and leveraging patient data for medical research advancement.
HealthLynked has announced the release of ARi, an AI-driven personal healthcare assistant that aims to revolutionize patient engagement and personalized care. The patent-pending technology offers exclusive access to paid members through the HealthLynked app. Key features include personalized healthcare recommendations, effortless scheduling with voice commands, proactive health tracking, and 24/7 intelligent assistance. ARi's platform integrates seamlessly with HealthLynked's ecosystem, allowing users to manage their healthcare efficiently.
CEO Dr. Michael Dent highlighted ARi's role in providing personalized medical care, emphasizing its capabilities like voice-driven profile creation, tailored recommendations, and AI-powered diagnostic support. The technology aims to enhance diagnostic accuracy and connect patients to appropriate care, fostering a more engaged and proactive approach to healthcare.
The release is seen as a significant milestone in HealthLynked's mission to deliver smarter, patient-centered healthcare by leveraging advanced AI to empower patients with better control over their health.
HealthLynked Corp. (OTCQB: HLYK) has appointed Jeremy Daniel as its new Chief Financial Officer (CFO), effective immediately. Daniel brings over two decades of experience in financial management, strategic planning, and organizational development. His most recent position was CFO at Innoveren Scientific, where he raised over $100M in funding through public and private equity markets and led successful acquisitions.
Daniel's previous roles include CFO at Regenerative Medicine Solutions and controller at Omnicare. He is a Certified Public Accountant (CPA) with an MBA from Xavier University. In his new role, he will oversee HealthLynked's financial strategy and operations, focusing on driving growth, operational efficiency, and shareholder value.
HealthLynked Corp. (OTCQB: HLYK) has received a $500,000 payment milestone from the sale of ACO Health Partners (AHP), representing their share of AHP's ACO shared savings for the 2023 performance period. This payment completes the total cash consideration of $3 million from the January 2023 sale, which included an initial $750,000 payment, $1.75 million in participation-based payments, and the current $500,000 milestone. The sale to Palm Beach ACO was a strategic move allowing HealthLynked to focus on its core healthcare technology and patient engagement services.
HealthLynked Corp. (OTCQB: HLYK) announced Q3 2024 financial results, revealing significant changes amid strategic restructuring. Revenue declined 56% year-over-year to $0.59 million in Q3 2024, with a nine-month revenue of $2.39 million, down 50% from 2023. The company reduced practice operating expenses by 39% to $0.80 million in Q3. Operating loss increased to $1.67 million, with a net loss of $1.97 million. The company is shifting focus from clinical operations to app-based services, with telemedicine now available nationwide. CEO Dr. Michael Dent provided $2.7 million in debt funding in 2024 to support the transition.